David Krempa
Corporate Officer/Principal at ETON PHARMACEUTICALS, INC.
Net worth: 64 899 $ as of 29/04/2024
Profile
David C.
Krempa is currently the Chief Business Officer at Eton Pharmaceuticals, Inc. He previously worked at Akorn, Inc. in Business Development-Sagent Pharmaceuticals.
Additionally, he worked as an Equity Analyst at Morningstar, Inc. (Research) from 2014 to 2015.
Mr. Krempa completed his undergraduate degree at DePaul University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/04/2024 | 20,801 ( 0.08% ) | 64 899 $ | 29/04/2024 |
David Krempa active positions
| Companies | Position | Start |
|---|---|---|
| ETON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 28/02/2023 |
Former positions of David Krempa
| Companies | Position | End |
|---|---|---|
Morningstar, Inc. (Research)
 Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Analyst-Equity | 28/02/2015 |
| AKORN, INC. | Corporate Officer/Principal | - |
Training of David Krempa
| DePaul University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ETON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Finance |
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
- Stock Market
- Insiders
- David Krempa
